Increased bilirubin rates may curb diabetic nephropathy risk

11/2/2012 | Medscape (free registration)

Higher baseline bilirubin levels were linked to a reduced risk of serum creatinine doubling and end-stage renal disease, researchers reported at the American Society of Nephrology annual meeting. The results suggest that treatments designed to increase bilirubin values may help prevent diabetic nephropathy.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY